Technology News and Research

RSS

NYU medical students use online 3D interactive virtual human body

First-year students at NYU School of Medicine were introduced to a pioneering online 3D interactive virtual human body called the BioDigital Human. This unique educational experience supplements the traditional use of human cadavers in anatomy instruction by allowing students to both view and interact with realistically simulated 3D organs and other anatomical structures.

9 Jan 2012

MPIIB, QIAGEN partner to develop latent TB diagnostic test

QIAGEN N.V. and the Max Planck Institute for Infection Biology (MPIIB), Department of Immunology have announced a new collaboration to develop a molecular diagnostic test to assess the risk of an individual with latent tuberculosis (TB) developing active TB disease during their lifetime.

From QIAGEN Manchester Limited 9 Jan 2012

Proteomics: Thermo Fisher Scientific and PREMIER Biosoft to co-market SimGlycan software

Thermo Fisher Scientific Inc., the world leader in serving science, and PREMIER Biosoft, have announced an agreement to co-market PREMIER Biosoft’s SimGlycan® software. The agreement aims to advance glycobiology by dramatically speeding the characterization of complex glycans through automated interpretation of the rich data produced by Thermo Scientific mass spectrometer systems.

From Thermo Fisher Scientific Inc. 8 Jan 2012

Georgia Bio announces 2012 Deals of the Year for pharma, biopharma and medical device companies

Georgia Bio announced its 2012 Deals of the Year for pharmaceutical, biopharmaceutical and medical device companies in four categories - public and private financings, fast growing companies, acquisitions and SBIR grants - reflecting a broad range of activity.

From Medtronic 7 Jan 2012

New Zealand life science and health IT companies to showcase their products in San Francisco

New Zealand is well known for its wines and stunning scenery, but the country is also a great source of innovation in the life sciences. A delegation of New Zealand life sciences companies who have reached key stages in their development are joining the throngs of international therapeutics, medical device and health IT companies in San Francisco, January 9 - 12 to showcase their products and capabilities to potential corporate partners and investors.

7 Jan 2012

New U.S. patent covers key element of Xencor's Xtend half-life prolongation technology

Xencor, Inc., a company using its proprietary Protein Design Automation (PDA) platform technology to engineer next-generation antibodies, announced today that the U.S. Patent and Trademark Office has issued Xencor a broad patent covering optimized monoclonal antibody variants and their application for extending in vivo half-life of antibodies.

7 Jan 2012

Magellan launches two fitness products

Magellan GPS announced today the launch of its first two products in its new fitness line: Switch and Switch Up. Designed to meet the needs of runners, cyclists, and multisport athletes, the new Switch Series is a powerful, adaptable, and customizable family of crossover GPS watches that will integrate seamlessly with third party sites.

7 Jan 2012

AccuGenomics to participate in OneMedForum at Sir Francis Drake hotel

AccuGenomics announced today that it will be attending the upcoming OneMedForum at the Sir Francis Drake hotel in San Francisco on January 9-12, coinciding with the JP Morgan Global Healthcare Conference.

7 Jan 2012

MINDBODY offers cloud-based business management software to over 15,000 clients

MINDBODY clients saw an average increase of 22% in holiday gift giving for health and wellness services this year over the 2010 season, with over 2,300 gift cards purchased as last-minute gifts on Christmas Eve.

7 Jan 2012

Silence completes siRNA research work with AstraZeneca, MedImmune

Silence Therapeutics plc, a leading RNA interference (RNAi) therapeutics company, announces the successful completion of its research work under the Research Collaboration and Delivery Collaboration with its partner AstraZeneca and its biologics arm, MedImmune.

7 Jan 2012

World's leading cleft charity performs 250,000th surgery in China

Smile Train, the world's leading cleft charity with over 2,200 partner surgeons operating in over 1,100 partner hospitals in over 80 countries, today announced that it has performed its 250,000th cleft repair surgery in China, since it began operations there in 1999.

7 Jan 2012

Lightlake intends to develop a treatment for premenstrual syndrome overeating

Lightlake Therapeutics Inc., an early stage biopharmaceutical company developing modern addiction treatments based on its expertise using opioid antagonists, announced today that it intends to develop a treatment for premenstrual syndrome (PMS) overeating using its patented technology involving opioid antagonists.

7 Jan 2012

OneMedForum San Francisco 2012 event to culminate with 'India Forum'

OneMedPlace today announced that its 5th annual "OneMedForum San Francisco 2012" event will culminate with the "India Forum" on the afternoon of January 11, 2012. The forum will examine how Western companies can capitalize in the booming India market.

7 Jan 2012

AnaptysBio enters new strategic alliances for antibody discovery

AnaptysBio, Inc., a privately-held therapeutic antibody company, today announced the initiation of new strategic alliances with two partners: Novartis and an undisclosed second pharmaceutical company.

7 Jan 2012

ARC commits additional $3.6M to support Project Medishare program in Haiti

The American Red Cross has committed an additional $3.6 million to underwrite operating expenses at Hospital Bernard Mevs Project Medishare Critical Care Trauma and Rehabilitation Program in Port-au-Prince, Haiti.

7 Jan 2012

The Tech Group, Pepex partner to develop Trio systems and sensor modules

Pepex Biomedical, Inc., a privately held company that has developed an all new proprietary sensor technology known as "CCM", announced today it has reached an agreement with The Tech Group , a division of West Pharmaceuticals Services, Inc., to be the premier manufacturer of the Trio systems and sensor modules.

7 Jan 2012

AB receives TÜV approval for Neptune waterproof sound processor in Europe

Advanced Bionics (AB), the global leader in cochlear implant technology, announced today that it received approval in Europe for Neptune, the world's first and only swimmable, waterproof sound processor.

7 Jan 2012

Fifi Delish, 50,000feet introduce ViviLeDish for young children

50,000feet, Inc. and Fifi Delish Holding, LLC announced the launch of ViviLeDish.com, an interactive platform designed to help young children develop healthy attitudes and habits about food, eating and exercise that will last a lifetime.

7 Jan 2012

PCI Biotech focuses on localised cancer therapy with minimum side effects

Side effects are currently the biggest problem with any cancer treatment. A Norwegian biotech company is drawing closer to the goal of creating a treatment which kills only cancer cells, leaving other cells unaffected.

7 Jan 2012

VisionGate achieves full automation of Cell-CT system

VisionGate, Inc., a company developing a revolutionary non-invasive test for the early detection of lung cancer and other applications, today reported that it has achieved full automation of its Cell-CT system, a proprietary imaging platform that generates high-resolution 3D biosignatures from intact cells.

7 Jan 2012